However, nothing is known about the effects of IGFBP7 on insulin secretion in type 2 diabetes, or if IGFBP7 could be a therapeutic target to improve insulin secretion in clinical type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.